CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases, Cell Communication and Signaling

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases, Cell Communication and Signaling

Mechanisms of SARS-CoV-2 entry into cells

SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist

Human Cell Receptors and Downstream Cascades: A Review of Molecular Aspects and Potential Therapeutic Targets in COVID-19, Archives of Pediatric Infectious Diseases

BSG/CD147 and ACE2 receptors facilitate SARS-CoV-2 infection of human iPS cell-derived kidney podocytes

Biology, Free Full-Text

SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Human cell receptors: potential drug targets to combat COVID-19

Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors - ScienceDirect

Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission - ScienceDirect

Innate immunity during SARS‐CoV‐2: evasion strategies and activation trigger hypoxia and vascular damage - Amor - 2020 - Clinical & Experimental Immunology - Wiley Online Library